Page last updated: 2024-09-04

2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and k 76 carboxylic acid

2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with k 76 carboxylic acid in 1 studies

Compound Research Comparison

Studies
(2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride)
Trials
(2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride)
Recent Studies (post-2010)
(2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride)
Studies
(k 76 carboxylic acid)
Trials
(k 76 carboxylic acid)
Recent Studies (post-2010) (k 76 carboxylic acid)
10003901

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, DK; Hancock, WW; Kobayashi, T; Koren, E; Neethling, FA; Niekrasz, M; Takagi, H; Taniguchi, S; Ye, Y1

Other Studies

1 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and k 76 carboxylic acid

ArticleYear
In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model.
    Transplantation proceedings, 1996, Volume: 28, Issue:2

    Topics: Animals; Benzamidines; Cells, Cultured; Complement Inactivator Proteins; Cytotoxicity, Immunologic; Graft Rejection; Graft Survival; Guanidines; Hydroxamic Acids; Kidney; Kidney Transplantation; Papio; Sesquiterpenes; Swine

1996